This content is machine translated Atopic dermatitis Biologics and JAK-i – the best of both worlds In Switzerland, both the currently approved monoclonal antibodies (dupilumab, tralokinumab, lebrikizumab) and the Janus kinase (JAK) inhibitors (baricitinib, abro-citinib, upadacitinib) can be used as “first-line” systemic therapy for patients with...…
View Post 6 min This content is machine translated Systemic lupus erythematosus What can belimumab and anifrolumab do? The monoclonal antibodies belimumab and anifrolumab are both approved for the treatment of systemic lupus erythematosus (SLE). Their response is considered to be highly effective. The point at which they…
View Post 16 min This content is machine translated Moderate to severe atopic dermatitis Changing therapeutic landscape – broad arsenal of treatment options New therapies in the form of specific antibodies and “small molecules” have ushered in a new era. Biologics intervene in the inflammatory process of atopic dermatitis by targeting individual cytokines.… CME-Test
View Post 5 min This content is machine translated Systemic lupus erythematosus (SLE) Besides Belimumab, other biologics soon available for the treatment of SLE? The therapeutic options available today allow the choice of an individualized therapeutic strategy. In addition to covventional immunosuppressants, biologics are becoming increasingly important. Belimumab has been approved as an add-on…
View Post 9 min This content is machine translated Multiple Sclerosis (MS) News on monoclonal antibody therapy A widespread chronic disease, affecting a majority of young adults, causes a vehement financial and societal interest to develop effective and tolerable therapies. In 2017 alone, two new monoclonal antibodies…
View Post 3 min This content is machine translated European Academy of Neurology (EAN) in Amsterdam Sexual dysfunction in MS Sexual dysfunction is a “side show” of MS disease. Nevertheless, a considerable proportion of all those affected suffer from it. Not only MS itself, but also the comorbidity “depression” plays…
